News from CNBC Business
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Crypto Assets
Shares
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Blockchain
Stablecoin
Etf
Sec
Eth
Bse
Ipo
Trade
Index
Solana
Earnings
Revenue
China
Coinbase
Inflation
Token
Wall Street
Nasdaq
Interest Rates
Sensex
Gold
Usd
Traders
Treasury
Trade War
Nse
Economy
Federal Reserve
Tesla
Profit
Bse Sensex
Digital Assets
Sp 500
Liquidity Pools
Uk Financial Services
Us Switzerland Tariffs
Refinery
Cross Border Settlement
Potential
Fed Independence
Bechtle Ag
Us Trading Partners
Bars
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Cnbc Business headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jun 17, 2025
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...
Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...
Read Full Article →
CNBC Business • May 01, 2025
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...
Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...
Read Full Article →